3D-TSE成像在单纯SRS治疗脑转移瘤中的重要性
本研究评估3D-TSE成像在脑转移瘤SRS计划中的临床价值,比较MPRAGE联合3D-TSE与单用MPRAGE。在未接受WBRT的患者中联合序列显著延长至远处颅内失败时间(11.4 vs 6.8个月,p=0.03),3D-TSE额外检出病灶比例更高(19.6% vs 12.0%,p<0.001)。
要点
- 未接受WBRT患者联合3D-TSE显著延长至远处颅内失败时间
- 3D-TSE额外检出病灶在未接受WBRT患者中比例更高
- 建议将双序列成像整合入SRS工作流程
核心结论
- 双序列MRI(MPRAGE+3D-TSE)可能改善大多数以SRS为主要治疗患者的至远处失败时间,应整合入SRS工作流程。
研究设计与样本
- 研究评估3D-TSE成像在脑转移瘤SRS计划中的临床效用,比较MPRAGE联合3D-TSE与单用MPRAGE。
主要发现
- 未接受WBRT患者(n=308)联合序列显著延长至远处颅内失败时间(11.4 vs 6.8个月,p=0.03)。
- 既往WBRT后SRS挽救患者(n=39)联合序列未显著延长至远处颅内失败时间(6.5 vs 5.6个月,p=0.76)。
- 3D-TSE额外检出病灶比例在未接受WBRT患者中为19.6%,高于WBRT后患者的12.0%(p<0.001)。
临床怎么用
- 对以SRS为主要治疗的脑转移瘤患者,SRS计划中可考虑整合MPRAGE联合3D-TSE双序列成像。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study evaluates the clinical utility of 3D turbo spin echo (3D-TSE) imaging in stereotactic radiosurgery (SRS) planning for brain metastases, examining the value of adding 3D-TSE to MPRAGE. Dual-sequence MRI (MPRAGE + 3D-TSE) significantly prolonged time to distant intracranial failure (DIF) in whole brain radiotherapy (WBRT)-naïve patients (n = 308, 11.4 vs. 6.8 months, p = 0.03), but not in patients previously treated with WBRT and salvaged with SRS (n = 39, 6.5 vs. 5.6 months, p = 0.76). Additional lesion detection attributed to 3D-TSE imaging was greater in WBRT-naïve (19.6 %) than in post-WBRT patients (12.0 %) (p < 0.001). The dual-sequence imaging may improve time to distant failure in the modern era for most patients treated with primary stereotactic radiosurgery and should be integrated into the SRS workflow.
引用
- Akdemir EY, DiStefano J, Abrams KJ, et al. Importance of 3D-TSE imaging for patients with brain metastasis treated with SRS alone. Radiother Oncol. 2025. PMID: 41027511. doi:10.1016/j.radonc.2025.111172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。